Show simple item record

Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

dc.contributor.authorStanley, Brooklyn
dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorBourdin, Arnaud
dc.contributor.authorCanonica, Giorgio Walter
dc.contributor.authorGurnell, Mark
dc.contributor.authorReddel, Helen K.
dc.contributor.authorHeaney, Liam G
dc.contributor.authorCarter, Victoria
dc.contributor.authorChapaner, Jatin
dc.contributor.authorTran, Trung N
dc.contributor.authorMaslova, Ekaterina
dc.contributor.authorMaslova, Ekaterina
dc.contributor.authorPrice, David
dc.date.accessioned2023-09-03T23:08:50Z
dc.date.available2023-09-03T23:08:50Z
dc.date.issued2022-08-01
dc.identifier218506399
dc.identifierff0156b9-0cc3-46e7-9f98-8824c2a8e9c7
dc.identifier.citationStanley , B , Menzies-Gow , A , Bourdin , A , Canonica , G W , Gurnell , M , Reddel , H K , Heaney , L G , Carter , V , Chapaner , J , Tran , T N , Maslova , E , Maslova , E & Price , D 2022 , ' Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma ' , European Respiratory Society (ERS) International Congress. , Barcelona , Spain , 4/09/22 - 6/09/22 .en
dc.identifier.citationconferenceen
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19767
dc.format.extent368966
dc.language.isoeng
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleOral corticosteroid (OCS) risk predictor for Type II Diabetes in asthmaen
dc.typeConference itemen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.date.embargoedUntil2023-09-04


Files in this item

Thumbnail
Name:
Stanley_etal_ERS_Oral_Corticos ...
Size:
360.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record